Clinical trial Recruiting at 1 site Observational Ages 18 to 45 Women only

Investigating the effects of dietary salicylates on preeclampsia

Official title: Nutritional Sources of Salicylates and Disorders of Placental Angiogenesis in Preeclampsia

Run by Poznan University of Life Sciences · NCT06239363 · Data updated 2026-11-12

This study is trying to see if the amount of salicylates in food can affect the risk of developing preeclampsia in pregnant women.

More Preeclampsia trials

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment500 (estimated)
SponsorPoznan University of Life Sciences
Academic / other
Locations1 site (Poznan)
StatusRecruiting
StartedJanuary 8, 2024
Main results expectedSeptember 28, 2027
Study endsSeptember 30, 2028
Registry record updatedApril 1, 2026
Trial IDNCT06239363 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant women aged 18-45, both healthy and those diagnosed with preeclampsia, who can provide informed consent.

Probably not a fit

Patients with detectable fetal defects, chronic hypertension, or other significant medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the relationship between maternal dietary intake of salicylates and the risk of developing preeclampsia, a serious pregnancy complication. It will compare the effects of naturally occurring salicylates found in food with those of low-dose aspirin on placental angiogenesis. The study will involve approximately 500 pregnant women, both healthy and those diagnosed with preeclampsia, aged 18-45 years. Participants will provide information about their daily food intake to assess the potential preventive effects of salicylates on preeclampsia development.

Why it matters

Potential benefit: If successful, this study could provide insights into dietary modifications that may help reduce the risk of preeclampsia in pregnant women.

How similar studies have gone: While the influence of salicylates on preeclampsia is a relatively novel area of investigation, previous studies have shown that low-dose aspirin can reduce the risk of preeclampsia, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age 18-45 years
* healthy women with no previous adverse medical history and women with diagnosed preeclampsia
* singleton pregnancy
* people who have the full ability to give informed consent.

Exclusion Criteria:

* pregnancies with detectable fetal defects, chromosomal abnormalities, genetic syndromes
* infections
* history of chronic hypertension, metabolic disorder before or during pregnancy, or the presence of high-risk factors such as heart diseases, diabetes, and renal diseases.

Where it's running

  • Poznan University of Life Sciences
    Poznan, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.